跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
recombinant hepatitis B protein
首页
药物
recombinant hepatitis B protein
recombinant hepatitis B protein
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Deletion of the beta 20-21 loop in HIV gp120 exposes the CD4 binding site for improved antibody binding and antibody induction
US 8628782 B2
申请人: BERKOWER IRA
优先权: 2010
US
4 件公开
Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis B virus sequences
US 7345026 B2
申请人: PASTEUR INSTITUT
优先权: 2003
US
3 件公开
RECOMBINANT ADENO-ASSOCIATED VIRUSES WITH ENHANCED LIVER TROPISM AND USES THEREOF
US 20240024514 A1
申请人: BEIJING SOLOBIO GENETECHNOLOGY CO LTD
优先权: 2020
CN
US
2 件公开
Recombinant protein for intracellular delivery of siRNA and composition comprising the same
US 8957186 B2
申请人: AHN HYUNG-JUN
优先权: 2011
US
2 件公开
Method for producing recombination human hepatitis B virus core antigen
CN 1434056 A
申请人: HANGHAOU TAISHI BIOLOG SCIENCE
优先权: 2002
CN
Variable region sequence of hepatitis B virus monoclonal antibody, gene engineering antibody containing the variable region and its use
CN 1609123 A
申请人: UNIV XIAMEN
优先权: 2003
CN
Variable region sequence of hepatitis B virus monoclonal antibody, gene engineering antibody containing variable region and application thereof
CN 101538326 A
申请人: UNIV XIAMEN
优先权: 2003
CN
Heat shock protein 65- multiple epitope hepatitis B virus core antigen recombinant protein (HSP65-HBcAg)
CN 1737147 B
申请人: BEIJING DIWEI HUAYU BIOTECHNOLOGY CO LTD
优先权: 2004
CN
Recombinant fusion protein carrying anthrax protective antigens epitope inserted to hepatitis B core antigen protein or its fragment and uses thereof
CN 101134781 A
申请人: MICROBE EPIDEMIC DISEASE INST
优先权: 2007
CN
Polynucleotides allowing the expression and secretion of recombinant HBsAg virus-like particles containing a foreign peptide, their production and use
US 2008166785 A1
申请人: SALA-SCHAEFFER MONICA
优先权: 2007
US
第 1 / 7 页
上一页
下一页
药物
反馈